AbbVie (ABBV) Stock Forecast for 2023 – 2026. Sell or Buy Prediction







Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…
How to Understand Social Security: 6 Legal & Financial Tips

January 25, 2024 How to Understand Social Security: 6 Legal & Financial Tips

Understanding social security can seem overwhelming, but it’s an important part of financial planning, particularly for retirement. The following 6 legal and financial…
Finding Energy Plans with Billig Strøm Rates

January 10, 2024 Finding Energy Plans with Billig Strøm Rates

It can be overwhelming to decide on the best plan when in a state where electricity is deregulated. The number of providers is…

AbbVie (ABBV) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: February 24, 2024 (12:03)

Sector: Healthcare

The share price of AbbVie Inc. (ABBV) now

Latest session on the 23rd of February for
AbbVie Inc. is positive
Trading Volume: 3941923
Open: 177.26 /  High: 178.905 /  Low: 177.011
What analysts predict: $179.25
52-week High/Low: $178.92 / $127.03

50/200 Day Moving Average: $162.13 / $148.4

This figure corresponds to the Average Price over the previous 50/200 days. For AbbVie stocks, the 50-day moving average is the support level today.

For AbbVie stocks, the 200-day moving average is the support level today.

Are you interested in AbbVie Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the AbbVie stock price in 2024, 2025, 2026, 2027, 2028. How much will one AbbVie share be worth in 2024 - 2028?

When should I take profit in AbbVie stock? When should I record a loss on AbbVie stock? What are analysts' forecasts for AbbVie stock? What is the future of AbbVie stock? We forecast AbbVie stock performance using neural networks based on historical data on AbbVie stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

AbbVie stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for AbbVie shares. This happens once a day.


Historical and forecast chart of AbbVie stock

The chart below shows the historical price of AbbVie stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the AbbVie stock price can be found in the table below.

Long-term forecasts by years.

Under the leadership of Richard Gonzalez, AbbVie’s management has raised their financial projection for 2023, particularly in regards to the adjusted diluted EPS. Initially anticipated to be in the range of $10.86–$11.06, it has been revised to a ballpark estimate of $11.19–$11.23.

Additionally, the company increased its quarterly cash dividend by 4.7%, raising it to a significant amount of $1.55.

Its primary products, Skyrizi (risankizumab) and Rinvoq (upadacitinib), continue to thrive with sales reaching an impressive $3.24 billion in Q3 of 2023 alone—a steep 55% surge compared to the earnings from the same period last year.

AbbVie’s strong Q3 financials have been instrumental in shifting our risk vs. reward sweet spot upwards—from $124 per share to around the $133–$134.5 range. Going forward, our stance remains at “hold” for AbbVie’s stock for approximately another year.

AbbVie, traded under ABBV on the NYSE and based in North Chicago, is one of the leading players in today’s global pharmaceutical industry. As we predicted earlier, since our last discussion on this subject matter, AbbVie’s share prices have seen further reduction. We attribute this upward revision from $124 per share to around $133–$134.5 primarily due to AbbVie’s healthy Q3 results.

Moreover, what strongly argues in favor of this revision is the company’s decision to raise its fiscal guidance for 2023’s adjusted diluted EPS—originally projected at $10.86–$11.06—now expected to fall within the range of $11.19–$11.23.

The company’s neuroscience division, in particular Qulipta (atogepant), put forth a strong performance that is largely responsible for this upward revision.

Approved for both episodic and chronic migraine prevention, the drug—dependent greatly on its anti-CGRP receptor mode of action and oral intake—saw an astounding 112.9% rise year-over-year in sales in Q3 2023, hitting $132 million.

AbbVie Inc. (NYSE:ABBV), an American drugmaker known for its innovative research and product development, recently announced a quarterly dividend of $1.48 per share on September 8. This tracks evenly with the company’s past dividend distribution and continues to position it as one of the brightest stars in our constellation of ‘dividend kings’. With a history of increasing dividends consistently over the last half-century, it boasts an attractively steady return for investors. As of September 23, AbbVie stock had a dividend yield of 3.88%.

In more recent news, as Q2 2023 draws to a close, investment management coming out of hedge funds seems slightly less bullish – numbering at 74 according to Insider Monkey’s tracking – compared to the previous quarter’s count of 75. Despite this marginal drop, however, the value contained within these stakes can’t be ignored – totalling over a whopping $2.37 billion.

Official site of the company

AbbVie daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 26 178.51 175.91 181.09 2.94
Feb 27 178.66 176.98 179.66 1.51
Feb 28 178.91 177.83 180.66 1.59
Feb 29 179.41 177.04 181.60 2.57
Mar 01 178.80 176.26 180.69 2.52
Mar 02 177.98 177.12 179.29 1.23
Mar 03 176.45 173.83 177.75 2.25
Mar 04 178.21 176.32 179.39 1.74
Mar 05 177.82 176.18 180.02 2.18
Mar 06 178.24 177.00 180.60 2.03
Mar 07 177.64 175.61 178.46 1.62
Mar 08 177.50 176.50 180.12 2.05
Mar 09 180.05 178.61 182.50 2.18
Mar 10 182.68 180.27 184.47 2.33
Mar 11 184.95 183.84 186.09 1.23
Mar 12 186.50 183.74 188.33 2.50
Mar 13 184.90 183.45 185.89 1.33
Mar 14 184.79 183.71 186.85 1.71
Mar 15 184.23 181.91 185.37 1.90
Mar 16 185.34 183.11 187.30 2.29
Mar 17 184.11 183.34 185.14 0.98
Mar 18 183.34 181.10 186.16 2.79
Mar 19 183.74 182.82 185.43 1.43
Mar 20 183.16 181.73 184.07 1.29
Mar 21 186.67 185.07 188.39 1.80
Mar 22 184.92 182.99 187.51 2.47
Mar 23 182.88 180.91 183.61 1.50
Mar 24 180.25 178.77 183.13 2.44
Mar 25 180.72 178.87 183.28 2.47
Mar 26 179.38 177.66 180.78 1.76

AbbVie Daily Price Targets


AbbVie Stock Forecast 02-26-2024.

Forecast target price for 02-26-2024: $178.51.
Positive dynamics for AbbVie shares will prevail with possible volatility of 2.859%.
Pessimistic target level: 175.91
Optimistic target level: 181.09

AbbVie Stock Forecast 02-27-2024.

Forecast target price for 02-27-2024: $178.66.
Positive dynamics for AbbVie shares will prevail with possible volatility of 1.492%.
Pessimistic target level: 176.98
Optimistic target level: 179.66

AbbVie Stock Forecast 02-28-2024.

Forecast target price for 02-28-2024: $178.91.
Positive dynamics for AbbVie shares will prevail with possible volatility of 1.564%.
Pessimistic target level: 177.83
Optimistic target level: 180.66

AbbVie Stock Forecast 02-29-2024.

Forecast target price for 02-29-2024: $179.41.
Positive dynamics for AbbVie shares will prevail with possible volatility of 2.509%.
Pessimistic target level: 177.04
Optimistic target level: 181.60

AbbVie Stock Forecast 03-01-2024.

Forecast target price for 03-01-2024: $178.80.
Negative dynamics for AbbVie shares will prevail with possible volatility of 2.454%.
Pessimistic target level: 176.26
Optimistic target level: 180.69

AbbVie Stock Forecast 03-02-2024.

Forecast target price for 03-02-2024: $177.98.
Negative dynamics for AbbVie shares will prevail with possible volatility of 1.211%.
Pessimistic target level: 177.12
Optimistic target level: 179.29

ABBV (ABBV) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Mar. 176.64 171.41 183.85 6.76
Apr. 180.74 173.07 190.13 8.97
May. 175.53 171.18 182.27 6.09
Jun. 164.30 156.41 167.32 6.52
Jul. 158.65 150.52 164.74 8.63
Aug. 169.18 165.39 173.92 4.90
Sep. 166.20 159.16 175.11 9.11
Oct. 163.41 153.87 173.35 11.24
Nov. 160.93 155.65 171.23 9.10
Dec. 162.08 152.10 166.75 8.79

AbbVie forecast for this year


AbbVie Stock Prediction for Mar 2024

An downtrend is forecast for this month with an optimal target price of $176.638. Pessimistic: $171.41. Optimistic: $183.85


AbbVie Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $180.736. Pessimistic: $173.07. Optimistic: $190.13


AbbVie Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $175.531. Pessimistic: $171.18. Optimistic: $182.27


AbbVie Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $164.297. Pessimistic: $156.41. Optimistic: $167.32


AbbVie Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $158.645. Pessimistic: $150.52. Optimistic: $164.74


AbbVie Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $169.179. Pessimistic: $165.39. Optimistic: $173.92


AbbVie Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $166.202. Pessimistic: $159.16. Optimistic: $175.11


AbbVie Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $163.409. Pessimistic: $153.87. Optimistic: $173.35


AbbVie Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $160.926. Pessimistic: $155.65. Optimistic: $171.23


AbbVie Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $162.084. Pessimistic: $152.10. Optimistic: $166.75



AbbVie (ABBV) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 168.18 159.70 176.39 9.46
Feb 174.37 164.32 181.20 9.31
Mar 167.53 162.57 178.25 8.80
Apr 171.15 165.26 174.85 5.48
May 172.66 165.61 180.53 8.26
Jun 180.12 176.37 183.57 3.92
Jul 187.61 184.16 198.72 7.33
Aug 197.21 187.91 202.58 7.24
Sep 193.43 187.39 205.50 8.81
Oct 178.26 169.99 189.53 10.31
Nov 176.98 167.64 181.79 7.79
Dec 181.79 176.12 189.36 6.99

AbbVie (ABBV) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 187.18 176.54 192.87 8.46
Feb 194.96 182.95 206.50 11.41
Mar 199.80 196.12 209.23 6.26
Apr 199.00 189.13 202.18 6.46
May 196.45 190.32 202.74 6.12
Jun 187.02 177.89 195.25 8.89
Jul 172.96 169.50 182.92 7.34
Aug 167.01 156.59 173.55 9.78
Sep 167.14 157.78 176.50 10.61
Oct 168.21 161.48 172.65 6.47
Nov 169.02 161.99 176.32 8.13
Dec 166.72 164.05 174.59 6.04

AbbVie (ABBV) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 165.92 161.14 170.30 5.38
Feb 167.51 157.59 174.61 9.75
Mar 175.95 167.09 185.10 9.73
Apr 185.39 177.52 192.50 7.78
May 188.80 179.28 197.25 9.11
Jun 191.21 183.26 194.43 5.74
Jul 184.33 180.79 193.18 6.41
Aug 189.20 186.17 196.61 5.31
Sep 189.50 177.67 192.99 7.93
Oct 204.51 192.89 214.00 9.86
Nov 213.83 204.25 224.95 9.20
Dec 229.74 217.79 235.25 7.42

AbbVie (ABBV) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 236.54 228.59 248.46 8.00
Feb 251.49 241.83 262.76 7.96
Mar 270.60 260.86 285.11 8.50
Apr 290.09 278.02 296.12 6.11
May 301.69 293.24 316.90 7.46
Jun 294.21 286.68 306.68 6.52
Jul 303.86 287.09 317.96 9.71
Aug 316.01 299.83 328.91 8.84
Sep 310.70 294.05 316.17 7.00
Oct 306.98 289.54 316.80 8.60
Nov 302.31 293.36 319.72 8.24
Dec 299.41 283.60 318.09 10.84

AbbVie information and performance

AbbVie Address

1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US

Market Capitalization: 314 151 338 000 $

Market capitalization of the AbbVie Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABBV shares in the company outstanding by the market price of one share.

EBITDA: 26 254 332 000 $

EBITDA of AbbVie is earnings before interest, income tax and depreciation of assets.

PE Ratio: 65.42

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.653

Price/earnings to growth

DPS: 5.99

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0349

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.72

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.668
Quarterly Revenue Growth YOY: -0.054
Trailing PE: 65.42

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 15.7

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 6.64

Enterprise Value (EV) /Revenue

EV To EBITDA: 26.66

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1765540000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

AbbVie (ABBV) stock dividend

AbbVie last paid dividends on 04/12/2024. The next scheduled payment will be on 05/15/2024. The amount of dividends is $5.99 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.